Wedbush Estimates NovoCure’s FY2026 Earnings (NASDAQ:NVCR)
NovoCure Limited (NASDAQ:NVCR – Free Report) – Equities researchers at Wedbush increased their FY2026 EPS estimates for NovoCure in a research report issued on Monday, June 2nd. Wedbush analyst D. Nierengarten now forecasts that the medical equipment provider will earn ($1.56) per share for the year, up from their previous forecast of ($1.57). Wedbush has […]
NovoCure Limited (NASDAQ:NVCR – Free Report) – Equities researchers at Wedbush increased their FY2026 EPS estimates for NovoCure in a research report issued on Monday, June 2nd. Wedbush analyst D. Nierengarten now forecasts that the medical equipment provider will earn ($1.56) per share for the year, up from their previous forecast of ($1.57). Wedbush has […]
